speb/financial-data huggingface dataset:
FMR.TO cash_flow (annual, 2025-07-31) — Asset Impairment Charge: 0.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Asset Impairment Charge: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Basic Average Shares: 13057598.00
FMR.TO income_statement (annual, 2025-07-31) — Basic EPS: -0.20
FMR.TO cash_flow (annual, 2025-07-31) — Beginning Cash Position: 55661.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 33502.00
FMR.TO balance_sheet (annual, 2025-07-31) — Capital Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Capital Stock: 35332342.00
FMR.TO balance_sheet (annual, 2025-07-31) — Cash And Cash Equivalents: 85855.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 85855.00
FMR.TO balance_sheet (annual, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 716426.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 716426.00
FMR.TO balance_sheet (annual, 2025-07-31) — Cash Financial: 85855.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Cash Financial: 85855.00
FMR.TO cash_flow (annual, 2025-07-31) — Cash Flow From Continuing Financing Activities: 99803.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: 100000.00
FMR.TO cash_flow (annual, 2025-07-31) — Cash Flow From Continuing Investing Activities: 184783.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: 89461.00
FMR.TO cash_flow (annual, 2025-07-31) — Cash Flow From Continuing Operating Activities: -254392.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: -137108.00
FMR.TO cash_flow (annual, 2025-07-31) — Change In Payables And Accrued Expense: 892462.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 265882.00
FMR.TO cash_flow (annual, 2025-07-31) — Change In Receivables: 254036.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Change In Receivables: 30466.00
FMR.TO cash_flow (annual, 2025-07-31) — Change In Working Capital: 1146498.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Change In Working Capital: 296348.00
FMR.TO cash_flow (annual, 2025-07-31) — Changes In Account Receivables: 254036.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: 30466.00
FMR.TO cash_flow (annual, 2025-07-31) — Changes In Cash: 30194.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Changes In Cash: 52353.00
FMR.TO balance_sheet (annual, 2025-07-31) — Common Stock: 35332342.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Common Stock: 35332342.00
FMR.TO balance_sheet (annual, 2025-07-31) — Common Stock Equity: -2262384.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: -2262384.00
FMR.TO balance_sheet (annual, 2025-07-31) — Current Assets: 825634.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Current Assets: 825634.00
FMR.TO balance_sheet (annual, 2025-07-31) — Current Liabilities: 2821602.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 2821602.00
FMR.TO income_statement (annual, 2025-07-31) — Diluted Average Shares: 13057598.00
FMR.TO income_statement (annual, 2025-07-31) — Diluted EPS: -0.20
FMR.TO income_statement (annual, 2025-07-31) — Diluted NI Availto Com Stockholders: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — EBIT: -2591224.00
FMR.TO income_statement (quarterly, 2025-07-31) — EBIT: -950331.00
FMR.TO income_statement (annual, 2025-07-31) — EBITDA: -2591224.00
FMR.TO income_statement (quarterly, 2025-07-31) — EBITDA: -950331.00
FMR.TO cash_flow (annual, 2025-07-31) — End Cash Position: 85855.00
FMR.TO cash_flow (quarterly, 2025-07-31) — End Cash Position: 85855.00
FMR.TO cash_flow (annual, 2025-07-31) — Financing Cash Flow: 99803.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: 100000.00
FMR.TO cash_flow (annual, 2025-07-31) — Free Cash Flow: -254392.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Free Cash Flow: -137108.00
FMR.TO cash_flow (annual, 2025-07-31) — Gain Loss On Investment Securities: 602001.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Gain Loss On Investment Securities: 544650.00
FMR.TO cash_flow (annual, 2025-07-31) — Gain Loss On Sale Of Business: 0.00
FMR.TO cash_flow (annual, 2025-07-31) — Gain Loss On Sale Of PPE: -14376.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Gain Loss On Sale Of PPE: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Gain On Sale Of Business: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Gain On Sale Of Ppe: 14376.00
FMR.TO income_statement (quarterly, 2025-07-31) — Gain On Sale Of Ppe: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Gain On Sale Of Security: -1172657.00
FMR.TO income_statement (quarterly, 2025-07-31) — Gain On Sale Of Security: -524910.00
FMR.TO income_statement (annual, 2025-07-31) — General And Administrative Expense: 1301133.00
FMR.TO income_statement (quarterly, 2025-07-31) — General And Administrative Expense: 325076.00
FMR.TO income_statement (annual, 2025-07-31) — Interest Expense: 23552.00
FMR.TO income_statement (quarterly, 2025-07-31) — Interest Expense: 11418.00
FMR.TO income_statement (annual, 2025-07-31) — Interest Expense Non Operating: 23552.00
FMR.TO income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 11418.00
FMR.TO income_statement (annual, 2025-07-31) — Interest Income: 3.00
FMR.TO income_statement (quarterly, 2025-07-31) — Interest Income: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Interest Income Non Operating: 3.00
FMR.TO income_statement (quarterly, 2025-07-31) — Interest Income Non Operating: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Invested Capital: -1995968.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Invested Capital: -1995968.00
FMR.TO cash_flow (annual, 2025-07-31) — Investing Cash Flow: 184783.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: 89461.00
FMR.TO cash_flow (annual, 2025-07-31) — Issuance Of Debt: 147000.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Issuance Of Debt: 100000.00
FMR.TO balance_sheet (annual, 2025-07-31) — Long Term Debt: 266416.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 266416.00
FMR.TO balance_sheet (annual, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 266416.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 266416.00
FMR.TO income_statement (annual, 2025-07-31) — Minority Interests: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — Minority Interests: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Net Debt: 180561.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Net Debt: 180561.00
FMR.TO cash_flow (annual, 2025-07-31) — Net Foreign Currency Exchange Gain Loss: -2119.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income Common Stockholders: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income Continuous Operations: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income From Continuing And Discontinued Operation: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: -961749.00
FMR.TO cash_flow (annual, 2025-07-31) — Net Income From Continuing Operations: -2614776.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Income Including Noncontrolling Interests: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: -961749.00
FMR.TO income_statement (annual, 2025-07-31) — Net Interest Income: -23549.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Interest Income: -11418.00
FMR.TO cash_flow (annual, 2025-07-31) — Net Investment Purchase And Sale: 184783.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: 89461.00
FMR.TO cash_flow (annual, 2025-07-31) — Net Issuance Payments Of Debt: 99803.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: 100000.00
FMR.TO income_statement (annual, 2025-07-31) — Net Non Operating Interest Income Expense: -23549.00
FMR.TO income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -11418.00
FMR.TO cash_flow (annual, 2025-07-31) — Net Short Term Debt Issuance: 99803.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Net Short Term Debt Issuance: 100000.00
FMR.TO balance_sheet (annual, 2025-07-31) — Net Tangible Assets: -2262384.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: -2262384.00
FMR.TO income_statement (annual, 2025-07-31) — Normalized EBITDA: -1432943.00
FMR.TO income_statement (quarterly, 2025-07-31) — Normalized EBITDA: -425421.00
FMR.TO income_statement (annual, 2025-07-31) — Normalized Income: -1456495.00
FMR.TO income_statement (quarterly, 2025-07-31) — Normalized Income: -436839.00
FMR.TO cash_flow (annual, 2025-07-31) — Operating Cash Flow: -254392.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: -137108.00
FMR.TO cash_flow (annual, 2025-07-31) — Operating Gains Losses: 585506.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: 544650.00
FMR.TO income_statement (annual, 2025-07-31) — Operating Income: -1432946.00
FMR.TO income_statement (quarterly, 2025-07-31) — Operating Income: -425421.00
FMR.TO income_statement (annual, 2025-07-31) — Operating Revenue: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Ordinary Shares Number: 13057598.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 13057598.00
FMR.TO balance_sheet (annual, 2025-07-31) — Other Equity Interest: 2028080.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Other Equity Interest: 2028080.00
FMR.TO income_statement (annual, 2025-07-31) — Other Gand A: 1261288.00
FMR.TO income_statement (quarterly, 2025-07-31) — Other Gand A: 322696.00
FMR.TO income_statement (annual, 2025-07-31) — Other Income Expense: -1158281.00
FMR.TO income_statement (quarterly, 2025-07-31) — Other Income Expense: -524910.00
FMR.TO cash_flow (annual, 2025-07-31) — Other Non Cash Items: 17636.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 5502.00
FMR.TO income_statement (annual, 2025-07-31) — Other Operating Expenses: 131813.00
FMR.TO income_statement (quarterly, 2025-07-31) — Other Operating Expenses: 100345.00
FMR.TO balance_sheet (annual, 2025-07-31) — Other Short Term Investments: 630571.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Other Short Term Investments: 630571.00
FMR.TO balance_sheet (annual, 2025-07-31) — Payables And Accrued Expenses: 2821602.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 2821602.00
FMR.TO balance_sheet (annual, 2025-07-31) — Prepaid Assets: 61866.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Prepaid Assets: 61866.00
FMR.TO income_statement (annual, 2025-07-31) — Pretax Income: -2614776.00
FMR.TO income_statement (quarterly, 2025-07-31) — Pretax Income: -961749.00
FMR.TO cash_flow (annual, 2025-07-31) — Purchase Of Investment: -1675.00
FMR.TO balance_sheet (annual, 2025-07-31) — Receivables: 47342.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Receivables: 47342.00
FMR.TO cash_flow (annual, 2025-07-31) — Repayment Of Debt: -47197.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Retained Earnings: -39622806.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Retained Earnings: -39622806.00
FMR.TO income_statement (annual, 2025-07-31) — Salaries And Wages: 39845.00
FMR.TO income_statement (quarterly, 2025-07-31) — Salaries And Wages: 2380.00
FMR.TO cash_flow (annual, 2025-07-31) — Sale Of Investment: 186458.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 91136.00
FMR.TO income_statement (annual, 2025-07-31) — Selling General And Administration: 1301133.00
FMR.TO income_statement (quarterly, 2025-07-31) — Selling General And Administration: 325076.00
FMR.TO balance_sheet (annual, 2025-07-31) — Share Issued: 13057598.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Share Issued: 13057598.00
FMR.TO cash_flow (annual, 2025-07-31) — Short Term Debt Issuance: 147000.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Short Term Debt Issuance: 100000.00
FMR.TO cash_flow (annual, 2025-07-31) — Short Term Debt Payments: -47197.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Short Term Debt Payments: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Special Income Charges: 14376.00
FMR.TO income_statement (quarterly, 2025-07-31) — Special Income Charges: 0.00
FMR.TO cash_flow (annual, 2025-07-31) — Stock Based Compensation: 37714.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 249.00
FMR.TO balance_sheet (annual, 2025-07-31) — Stockholders Equity: -2262384.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: -2262384.00
FMR.TO balance_sheet (annual, 2025-07-31) — Tangible Book Value: -2262384.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: -2262384.00
FMR.TO income_statement (annual, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (annual, 2025-07-31) — Tax Rate For Calcs: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Assets: 825634.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Assets: 825634.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Capitalization: -1995968.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Capitalization: -1995968.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Debt: 266416.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Debt: 266416.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Equity Gross Minority Interest: -2262384.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: -2262384.00
FMR.TO income_statement (annual, 2025-07-31) — Total Expenses: 1432946.00
FMR.TO income_statement (quarterly, 2025-07-31) — Total Expenses: 425421.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Liabilities Net Minority Interest: 3088018.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 3088018.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (annual, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 266416.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 266416.00
FMR.TO income_statement (annual, 2025-07-31) — Total Unusual Items: -1158281.00
FMR.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items: -524910.00
FMR.TO income_statement (annual, 2025-07-31) — Total Unusual Items Excluding Goodwill: -1158281.00
FMR.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -524910.00
FMR.TO cash_flow (annual, 2025-07-31) — Unrealized Gain Loss On Investment Securities: 573030.00
FMR.TO cash_flow (quarterly, 2025-07-31) — Unrealized Gain Loss On Investment Securities: -22108.00
FMR.TO balance_sheet (annual, 2025-07-31) — Working Capital: -1995968.00
FMR.TO balance_sheet (quarterly, 2025-07-31) — Working Capital: -1995968.00
FMR.TO income_statement (annual, 2025-07-31) — Write Off: 0.00
FMR.TO income_statement (quarterly, 2025-07-31) — Write Off: 0.00
FMR.TO income_statement (quarterly, 2025-10-31) — +Operating Expense: 160560.00
FMR.TO income_statement (quarterly, 2025-10-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 53487.00
FMR.TO income_statement (quarterly, 2025-10-31) — Basic Average Shares: 15385533.00
FMR.TO income_statement (quarterly, 2025-10-31) — Basic EPS: 0.08
FMR.TO cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 85855.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 36239842.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 39014.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 866940.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Cash Financial: 39014.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: 0.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: 183772.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: -230613.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: -84672.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Change In Receivables: 11727.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -72945.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: 11727.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Changes In Cash: -46841.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Common Stock: 36239842.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: -50392.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Current Assets: 964422.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 741351.00
FMR.TO income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 15385533.00
FMR.TO income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.08
FMR.TO income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — EBIT: 1308743.00
FMR.TO income_statement (quarterly, 2025-10-31) — EBITDA: 1308743.00
FMR.TO cash_flow (quarterly, 2025-10-31) — End Cash Position: 39014.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: 0.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Free Cash Flow: -230613.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Gain Loss On Investment Securities: -59203.00
FMR.TO income_statement (quarterly, 2025-10-31) — Gain On Sale Of Security: 380123.00
FMR.TO income_statement (quarterly, 2025-10-31) — General And Administrative Expense: 145418.00
FMR.TO income_statement (quarterly, 2025-10-31) — Interest Expense: 4251.00
FMR.TO income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 4251.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Invested Capital: 223071.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Investing Cash Flow: 183772.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Issuance Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt: 273463.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Long Term Debt And Capital Lease Obligation: 273463.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Issuance: 0.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Long Term Debt Payments: 0.00
FMR.TO income_statement (quarterly, 2025-10-31) — Minority Interests: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Net Debt: 234449.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income Common Stockholders: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income Continuous Operations: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing And Discontinued Operation: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income From Continuing Operation Net Minority Interest: 1304492.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Net Income From Continuing Operations: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Income Including Noncontrolling Interests: 1304492.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Interest Income: -4251.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Net Investment Purchase And Sale: 183772.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Net Issuance Payments Of Debt: 0.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Net Long Term Debt Issuance: 0.00
FMR.TO income_statement (quarterly, 2025-10-31) — Net Non Operating Interest Income Expense: -4251.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Net Tangible Assets: -50392.00
FMR.TO income_statement (quarterly, 2025-10-31) — Normalized EBITDA: -160560.00
FMR.TO income_statement (quarterly, 2025-10-31) — Normalized Income: 55584.45
FMR.TO cash_flow (quarterly, 2025-10-31) — Operating Cash Flow: -230613.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Operating Gains Losses: -1148383.00
FMR.TO income_statement (quarterly, 2025-10-31) — Operating Income: -160560.00
FMR.TO income_statement (quarterly, 2025-10-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Ordinary Shares Number: 16687598.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Other Equity Interest: 2028080.00
FMR.TO income_statement (quarterly, 2025-10-31) — Other Gand A: 144317.00
FMR.TO income_statement (quarterly, 2025-10-31) — Other Income Expense: 1469303.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Other Non Cash Items: 7047.00
FMR.TO income_statement (quarterly, 2025-10-31) — Other Operating Expenses: 15142.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Other Short Term Investments: 827926.00
FMR.TO income_statement (quarterly, 2025-10-31) — Other Special Charges: -1089180.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Payables And Accrued Expenses: 741351.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Prepaid Assets: 43995.00
FMR.TO income_statement (quarterly, 2025-10-31) — Pretax Income: 1304492.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Receivables: 53487.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Retained Earnings: -38318314.00
FMR.TO income_statement (quarterly, 2025-10-31) — Salaries And Wages: 1101.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Sale Of Investment: 183772.00
FMR.TO income_statement (quarterly, 2025-10-31) — Selling General And Administration: 145418.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Share Issued: 16687598.00
FMR.TO income_statement (quarterly, 2025-10-31) — Special Income Charges: 1089180.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Stock Based Compensation: 1101.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Stockholders Equity: -50392.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Tangible Book Value: -50392.00
FMR.TO income_statement (quarterly, 2025-10-31) — Tax Effect Of Unusual Items: 220395.45
FMR.TO income_statement (quarterly, 2025-10-31) — Tax Rate For Calcs: 0.15
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Assets: 964422.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Capitalization: 223071.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Debt: 273463.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Equity Gross Minority Interest: -50392.00
FMR.TO income_statement (quarterly, 2025-10-31) — Total Expenses: 160560.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Liabilities Net Minority Interest: 1014814.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Total Non Current Liabilities Net Minority Interest: 273463.00
FMR.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items: 1469303.00
FMR.TO income_statement (quarterly, 2025-10-31) — Total Unusual Items Excluding Goodwill: 1469303.00
FMR.TO cash_flow (quarterly, 2025-10-31) — Unrealized Gain Loss On Investment Securities: -321925.00
FMR.TO balance_sheet (quarterly, 2025-10-31) — Working Capital: 223071.00
FMR.TO income_statement (quarterly, 2026-01-31) — +Operating Expense: 447751.00
FMR.TO income_statement (quarterly, 2026-01-31) — +Total Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Accounts Receivable: 59899.00
FMR.TO income_statement (quarterly, 2026-01-31) — Basic Average Shares: 16687598.00
FMR.TO income_statement (quarterly, 2026-01-31) — Basic EPS: -0.03
FMR.TO cash_flow (quarterly, 2026-01-31) — Beginning Cash Position: 39014.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Capital Stock: 36239842.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Cash And Cash Equivalents: 25496.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Cash Cash Equivalents And Short Term Investments: 771963.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Cash Financial: 25496.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Financing Activities: 0.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Investing Activities: 81952.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Cash Flow From Continuing Operating Activities: -95470.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Change In Payables And Accrued Expense: 54496.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Change In Receivables: 10298.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Change In Working Capital: 64794.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Changes In Account Receivables: 10298.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Changes In Cash: -13518.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Common Stock: 36239842.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Common Stock Equity: -216710.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Current Assets: 859147.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Current Liabilities: 445507.00
FMR.TO income_statement (quarterly, 2026-01-31) — Diluted Average Shares: 16687598.00
FMR.TO income_statement (quarterly, 2026-01-31) — Diluted EPS: -0.03
FMR.TO income_statement (quarterly, 2026-01-31) — Diluted NI Availto Com Stockholders: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — EBIT: -446124.00
FMR.TO income_statement (quarterly, 2026-01-31) — EBITDA: -446124.00
FMR.TO cash_flow (quarterly, 2026-01-31) — End Cash Position: 25496.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Financing Cash Flow: 0.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Free Cash Flow: -95470.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Gain Loss On Investment Securities: 359860.00
FMR.TO income_statement (quarterly, 2026-01-31) — Gain On Sale Of Security: 1627.00
FMR.TO income_statement (quarterly, 2026-01-31) — General And Administrative Expense: 412761.00
FMR.TO income_statement (quarterly, 2026-01-31) — Interest Expense: 7047.00
FMR.TO income_statement (quarterly, 2026-01-31) — Interest Expense Non Operating: 7047.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Invested Capital: 413640.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Investing Cash Flow: 81952.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Issuance Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt: 630350.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Long Term Debt And Capital Lease Obligation: 630350.00
FMR.TO income_statement (quarterly, 2026-01-31) — Minority Interests: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Net Debt: 604854.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income Common Stockholders: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income Continuous Operations: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing And Discontinued Operation: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income From Continuing Operation Net Minority Interest: -453171.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Net Income From Continuing Operations: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Income Including Noncontrolling Interests: -453171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Interest Income: -7047.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Net Investment Purchase And Sale: 81952.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Net Issuance Payments Of Debt: 0.00
FMR.TO income_statement (quarterly, 2026-01-31) — Net Non Operating Interest Income Expense: -7047.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Net Tangible Assets: -216710.00
FMR.TO income_statement (quarterly, 2026-01-31) — Normalized EBITDA: -447751.00
FMR.TO income_statement (quarterly, 2026-01-31) — Normalized Income: -454798.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Operating Cash Flow: -95470.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Operating Gains Losses: 359860.00
FMR.TO income_statement (quarterly, 2026-01-31) — Operating Income: -447751.00
FMR.TO income_statement (quarterly, 2026-01-31) — Operating Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Ordinary Shares Number: 16687598.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Other Equity Interest: 2314933.00
FMR.TO income_statement (quarterly, 2026-01-31) — Other Gand A: 126409.00
FMR.TO income_statement (quarterly, 2026-01-31) — Other Income Expense: 1627.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Other Non Cash Items: 7048.00
FMR.TO income_statement (quarterly, 2026-01-31) — Other Operating Expenses: 34990.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Other Short Term Investments: 746467.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Payables And Accrued Expenses: 445507.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Prepaid Assets: 27285.00
FMR.TO income_statement (quarterly, 2026-01-31) — Pretax Income: -453171.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Receivables: 59899.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Retained Earnings: -38771485.00
FMR.TO income_statement (quarterly, 2026-01-31) — Salaries And Wages: 286352.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Sale Of Investment: 146171.00
FMR.TO income_statement (quarterly, 2026-01-31) — Selling General And Administration: 412761.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Share Issued: 16687598.00
FMR.TO income_statement (quarterly, 2026-01-31) — Special Income Charges: 0.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Stock Based Compensation: 286352.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Stockholders Equity: -216710.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Tangible Book Value: -216710.00
FMR.TO income_statement (quarterly, 2026-01-31) — Tax Effect Of Unusual Items: 0.00
FMR.TO income_statement (quarterly, 2026-01-31) — Tax Rate For Calcs: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Assets: 859147.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Capitalization: 413640.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Debt: 630350.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Equity Gross Minority Interest: -216710.00
FMR.TO income_statement (quarterly, 2026-01-31) — Total Expenses: 447751.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Liabilities Net Minority Interest: 1075857.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Total Non Current Liabilities Net Minority Interest: 630350.00
FMR.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items: 1627.00
FMR.TO income_statement (quarterly, 2026-01-31) — Total Unusual Items Excluding Goodwill: 1627.00
FMR.TO cash_flow (quarterly, 2026-01-31) — Unrealized Gain Loss On Investment Securities: -360353.00
FMR.TO balance_sheet (quarterly, 2026-01-31) — Working Capital: 413640.00
FMR.TO income_statement (quarterly, 2026-04-30) — +Operating Expense: 153825.00
FMR.TO income_statement (quarterly, 2026-04-30) — +Total Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Accounts Receivable: 19105.00
FMR.TO income_statement (quarterly, 2026-04-30) — Basic Average Shares: 17125051.00
FMR.TO income_statement (quarterly, 2026-04-30) — Basic EPS: 0.01
FMR.TO cash_flow (quarterly, 2026-04-30) — Beginning Cash Position: 25496.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Capital Stock: 36472969.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Cash And Cash Equivalents: 531645.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Cash Cash Equivalents And Short Term Investments: 1170830.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Cash Financial: 531645.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Financing Activities: 233127.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Investing Activities: 346887.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Cash Flow From Continuing Operating Activities: -73865.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Change In Payables And Accrued Expense: 33697.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Change In Receivables: 57143.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Change In Working Capital: 90840.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Changes In Account Receivables: 57143.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Changes In Cash: 506149.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Common Stock: 36472969.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Common Stock Equity: 127095.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Current Assets: 1243316.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Current Liabilities: 466007.00
FMR.TO income_statement (quarterly, 2026-04-30) — Diluted Average Shares: 17125051.00
FMR.TO income_statement (quarterly, 2026-04-30) — Diluted EPS: 0.01
FMR.TO income_statement (quarterly, 2026-04-30) — Diluted NI Availto Com Stockholders: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — EBIT: 128019.00
FMR.TO income_statement (quarterly, 2026-04-30) — EBITDA: 128019.00
FMR.TO cash_flow (quarterly, 2026-04-30) — End Cash Position: 531645.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Financing Cash Flow: 233127.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Free Cash Flow: -73865.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Gain Loss On Investment Securities: -73924.00
FMR.TO income_statement (quarterly, 2026-04-30) — Gain On Sale Of Ppe: 0.00
FMR.TO income_statement (quarterly, 2026-04-30) — Gain On Sale Of Security: 281844.00
FMR.TO income_statement (quarterly, 2026-04-30) — General And Administrative Expense: 153825.00
FMR.TO income_statement (quarterly, 2026-04-30) — Interest Expense: 17341.00
FMR.TO income_statement (quarterly, 2026-04-30) — Interest Expense Non Operating: 17341.00
FMR.TO income_statement (quarterly, 2026-04-30) — Interest Income: 0.00
FMR.TO income_statement (quarterly, 2026-04-30) — Interest Income Non Operating: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Invested Capital: 777309.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Investing Cash Flow: 346887.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Issuance Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Loans Receivable: 42446.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt: 650214.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Long Term Debt And Capital Lease Obligation: 650214.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Net Debt: 118569.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Net Foreign Currency Exchange Gain Loss: 0.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income Common Stockholders: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income Continuous Operations: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing And Discontinued Operation: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income From Continuing Operation Net Minority Interest: 110678.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Net Income From Continuing Operations: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Income Including Noncontrolling Interests: 110678.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Interest Income: -17341.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Net Investment Purchase And Sale: 389333.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Net Issuance Payments Of Debt: 0.00
FMR.TO income_statement (quarterly, 2026-04-30) — Net Non Operating Interest Income Expense: -17341.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Net Tangible Assets: 127095.00
FMR.TO income_statement (quarterly, 2026-04-30) — Normalized EBITDA: -153825.00
FMR.TO income_statement (quarterly, 2026-04-30) — Normalized Income: -58428.40
FMR.TO cash_flow (quarterly, 2026-04-30) — Operating Cash Flow: -73865.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Operating Gains Losses: -73924.00
FMR.TO income_statement (quarterly, 2026-04-30) — Operating Income: -153825.00
FMR.TO income_statement (quarterly, 2026-04-30) — Operating Revenue: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Ordinary Shares Number: 17520931.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Other Equity Interest: 2314933.00
FMR.TO income_statement (quarterly, 2026-04-30) — Other Gand A: 153975.00
FMR.TO income_statement (quarterly, 2026-04-30) — Other Income Expense: 281844.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Other Non Cash Items: 6818.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Other Short Term Investments: 639185.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Payables And Accrued Expenses: 466007.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Prepaid Assets: 10935.00
FMR.TO income_statement (quarterly, 2026-04-30) — Pretax Income: 110678.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Purchase Of Investment: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Receivables: 61551.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Repayment Of Debt: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Retained Earnings: -38660807.00
FMR.TO income_statement (quarterly, 2026-04-30) — Salaries And Wages: -150.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Sale Of Investment: 389333.00
FMR.TO income_statement (quarterly, 2026-04-30) — Selling General And Administration: 153825.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Share Issued: 17520931.00
FMR.TO income_statement (quarterly, 2026-04-30) — Special Income Charges: 0.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Stock Based Compensation: -150.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Stockholders Equity: 127095.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Tangible Book Value: 127095.00
FMR.TO income_statement (quarterly, 2026-04-30) — Tax Effect Of Unusual Items: 112737.60
FMR.TO income_statement (quarterly, 2026-04-30) — Tax Rate For Calcs: 0.40
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Assets: 1243316.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Capitalization: 777309.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Debt: 650214.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Equity Gross Minority Interest: 127095.00
FMR.TO income_statement (quarterly, 2026-04-30) — Total Expenses: 153825.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Liabilities Net Minority Interest: 1116221.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Assets: 0.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Total Non Current Liabilities Net Minority Interest: 650214.00
FMR.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items: 281844.00
FMR.TO income_statement (quarterly, 2026-04-30) — Total Unusual Items Excluding Goodwill: 281844.00
FMR.TO cash_flow (quarterly, 2026-04-30) — Unrealized Gain Loss On Investment Securities: -208127.00
FMR.TO balance_sheet (quarterly, 2026-04-30) — Working Capital: 777309.00
FMS balance_sheet (annual, 2021-12-31) — Cash Equivalents: 556521000.00
FMS balance_sheet (annual, 2021-12-31) — Cash Financial: 925134000.00
FMS balance_sheet (annual, 2021-12-31) — Commercial Paper: 715153000.00
FMS cash_flow (annual, 2021-12-31) — Common Stock Dividend Paid: -392455000.00
FMS balance_sheet (annual, 2021-12-31) — Interest Payable: 68558000.00
FMS cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 6511000.00
FMS cash_flow (annual, 2021-12-31) — Stock Based Compensation: 0.00
FMS income_statement (annual, 2022-12-31) — +Operating Expense: 3438955000.00
FMS income_statement (annual, 2022-12-31) — +Total Revenue: 19398017000.00
FMS balance_sheet (annual, 2022-12-31) — Accounts Payable: 951584000.00
FMS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3670098000.00
FMS balance_sheet (annual, 2022-12-31) — Accrued Interest Receivable: 450000.00
FMS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9898528000.00
FMS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3372799000.00
FMS balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
FMS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 340975000.00
FMS income_statement (annual, 2022-12-31) — Basic Average Shares: 586492860.00
FMS income_statement (annual, 2022-12-31) — Basic EPS: 1.15
FMS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1481655000.00
FMS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 4424685000.00
FMS cash_flow (annual, 2022-12-31) — Capital Expenditure: -723988000.00
FMS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4678763000.00
FMS balance_sheet (annual, 2022-12-31) — Capital Stock: 293413000.00
FMS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1273787000.00
FMS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 1428663000.00
FMS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -395556000.00
FMS balance_sheet (annual, 2022-12-31) — Cash Equivalents: 362772000.00
FMS balance_sheet (annual, 2022-12-31) — Cash Financial: 911015000.00
FMS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -1617360000.00
FMS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -734725000.00
FMS cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 2167379000.00
FMS cash_flow (annual, 2022-12-31) — Change In Account Payable: -356789000.00
FMS cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 325680000.00
FMS cash_flow (annual, 2022-12-31) — Change In Inventory: -204307000.00
FMS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 154031000.00
FMS cash_flow (annual, 2022-12-31) — Change In Payable: -31109000.00
FMS cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -31109000.00
FMS cash_flow (annual, 2022-12-31) — Change In Receivables: -46682000.00
FMS cash_flow (annual, 2022-12-31) — Change In Tax Payable: 325680000.00
FMS cash_flow (annual, 2022-12-31) — Change In Working Capital: -128067000.00
FMS cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -46682000.00
FMS cash_flow (annual, 2022-12-31) — Changes In Cash: -184706000.00
FMS balance_sheet (annual, 2022-12-31) — Commercial Paper: 495424000.00
FMS balance_sheet (annual, 2022-12-31) — Common Stock: 293413000.00
FMS cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -395556000.00
FMS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 13989453000.00
FMS cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
FMS balance_sheet (annual, 2022-12-31) — Construction In Progress: 362838000.00
FMS income_statement (annual, 2022-12-31) — Cost Of Revenue: 14504328000.00
FMS balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 262568000.00
FMS balance_sheet (annual, 2022-12-31) — Current Assets: 8203455000.00
FMS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 673825000.00
FMS balance_sheet (annual, 2022-12-31) — Current Debt: 1342829000.00
FMS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 2016654000.00
FMS balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 105721000.00
FMS balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 105721000.00
FMS balance_sheet (annual, 2022-12-31) — Current Liabilities: 6467314000.00
FMS balance_sheet (annual, 2022-12-31) — Current Provisions: 370796000.00
FMS cash_flow (annual, 2022-12-31) — Deferred Income Tax: -41471000.00
FMS cash_flow (annual, 2022-12-31) — Deferred Tax: -41471000.00
FMS cash_flow (annual, 2022-12-31) — Depreciation: 1838363000.00
FMS cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1838363000.00
FMS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1838363000.00
FMS balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 801147000.00
FMS income_statement (annual, 2022-12-31) — Diluted Average Shares: 586492860.00
FMS income_statement (annual, 2022-12-31) — Diluted EPS: 1.15
FMS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 673405000.00
FMS cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 95213000.00
FMS balance_sheet (annual, 2022-12-31) — Duefrom Related Parties Current: 140072000.00
FMS income_statement (annual, 2022-12-31) — EBIT: 1579418000.00
FMS income_statement (annual, 2022-12-31) — EBITDA: 3417781000.00
FMS income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 214761000.00
FMS cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -66559000.00
FMS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -23162000.00
FMS balance_sheet (annual, 2022-12-31) — Employee Benefits: 620128000.00
FMS cash_flow (annual, 2022-12-31) — End Cash Position: 1273787000.00
FMS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1617360000.00
FMS balance_sheet (annual, 2022-12-31) — Finished Goods: 1310995000.00
FMS cash_flow (annual, 2022-12-31) — Free Cash Flow: 1443391000.00
FMS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -99268000.00
FMS income_statement (annual, 2022-12-31) — Gain On Sale Of Business: -64734000.00
FMS income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 47173000.00
FMS income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -140179000.00
FMS balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -388468000.00
FMS income_statement (annual, 2022-12-31) — General And Administrative Expense: 2369494000.00
FMS balance_sheet (annual, 2022-12-31) — Goodwill: 15791181000.00
FMS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 17309858000.00
FMS balance_sheet (annual, 2022-12-31) — Gross PPE: 18238336000.00
FMS income_statement (annual, 2022-12-31) — Gross Profit: 4893689000.00
FMS balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 19777000.00
FMS balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 274821000.00
FMS balance_sheet (annual, 2022-12-31) — Income Tax Payable: 143932000.00
FMS income_statement (annual, 2022-12-31) — Interest Expense: 360139000.00
FMS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 360139000.00
FMS income_statement (annual, 2022-12-31) — Interest Income: 67663000.00
FMS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 67663000.00
FMS cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -350681000.00
FMS balance_sheet (annual, 2022-12-31) — Interest Payable: 58266000.00
FMS cash_flow (annual, 2022-12-31) — Interest Received Cfo: 67663000.00
FMS balance_sheet (annual, 2022-12-31) — Inventory: 2296214000.00
FMS balance_sheet (annual, 2022-12-31) — Invested Capital: 22503016000.00
FMS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -734725000.00
FMS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 615796000.00
FMS balance_sheet (annual, 2022-12-31) — Investments And Advances: 1389520000.00
FMS balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 717267000.00
FMS balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 56457000.00
FMS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1704016000.00
FMS balance_sheet (annual, 2022-12-31) — Land And Improvements: 109191000.00